[
    "{\"step_by_step_thinking\": \"EGFR mutation status is crucial for determining the treatment plan for patients with advanced non-small cell lung cancer. Traditionally, this mutation status is determined by analyzing tissue samples. However, obtaining tissue samples can be invasive and challenging in some cases. Recent advancements in medical technology have made it possible to analyze EGFR mutation status using serum, which can be obtained through a simple blood draw. This method is known as liquid biopsy and it has been proven to be effective in detecting EGFR mutations.\", \"answer_choice\": \"A\"}"
]